the market?
SUCAMPO PHARMACEUTICALS, INC.
NASDAQ: SCMP
8.85
0.23
(2.67%)
| Today's Open | $8.52 |
|---|---|
| Previous Close | $8.62 |
| Daily Range | $8.41 - $8.88 |
| 52-Week Range | $3.78 - $10.48 |
| Market Cap | $371.4M |
| P/E Ratio | 95.78 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 153,834 |
| Average Daily Volume | 387,657 |
| Current FY EPS | -$0.09 |
How do you think SCMP
will perform against the market?
Top SCMP Bull/Bear Pitches
zzlangerhans (< 20)
Submitted
August 11, 2011
I recently did OK on a short-term outperform of Sucampo, and jumped out before the stock turned back south. The stock has dropped moderately after the earnings PR today but I don't see the cause for c … More
drugncover (< 20)
Submitted
October 5, 2007
Talk about inside dealing... reading the prospectus of this company is like wading through a swamp. They hold certain rights to all their compounds in a separate company, that the CEO of this company … More
News & Commentary
A New Cure for Painkiller Constipation
The first oral medication for opioid related constipation receives FDA approval.New Stock Coverage: T-Mobile Gets Lukewarm Reception
Wall Street ratings agencies set the tone for today's stock market.Sucampo Pharmaceuticals Announces First Quarter 2013 Results and Operating Highlights Teleconference
Sector
Healthcare
Industry
Drugs
SUCAMPO PHARMACEUTICALS, INC. (SCMP) Description
An emerging pharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. Website: http://www.sucampo.com/
CEO Rating by Glassdoor
More details for Sucampo Jobs
Sucampo reviews from employees
